Pharmaceutical Raw Material Telaprevir (CAS: 402957-28-2)

Pharmaceutical Raw Material Telaprevir with Fast Delivery(CAS: 402957-28-2)
 
========================
Chemical Information:
Quick Details: 
Product Name: Telaprevir
Other Names: Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-;VX-950;VX-950 (Teleprevir);(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;Telaprevir;(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide VX-950;VX-950(Telaprevir);(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxaMido)acetaMido)-3,3-diMethylbutanoyl)-N-((S)-1-(cyclopropylaMino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxaMide
Model No.: CUR-526
CAS No.: 402957-28-2
Molecular Formula: C36H53N7O6
Molecular Weight: 679.85
Appearance: White Solid
Melting Point: N/A
Purity: 99%+
COA: Available
MSDS: Available
Spectrum: Available
Suitable People: ALL People
Product Specifications: Pharmaceutical Grade 
Standard: Qualified
MOQ(Minimum Order Quantity): 10g
Payment: L/C, T/T, Western Union
Shipment: EMS, DHL, FedEx, TNT
Payment:T/T, Western Union and Money Gram
Delivery:Within 24hours After Your Payment
Packing: Aluminium Foil Bag or as Required    
Brand: Biocar
Origion: Hubei,China  
Export Markets: Global   
 
========================
Product Description:
Telaprevir is a peptidomimetic inhibitor of hepatitis C virus protease.
 
Physicians prescribe the antiviral medication telaprevir in conjunction with peginterferon alfa and ribavirin for the treatment of the hepatitis C virus (HCV). The HCV drug not only increases the likelihood of disabling the virus but also may decrease the amount of time patients require treatment. The treatment regimen may cause anemia and typically produces flu-like symptoms. Telaprevir interacts with many prescribed medications.
 
Telaprevir is a protease inhibitor antiviral medication that interferes with the NS3/4A serine protease. This enzyme is responsible for protein maturity and protein adhesion. When these processes are inhibited, the virus cannot replicate. Genotype 1 hepatitis C virus is the most common strain of the disease and is also most resistant to treatment. Treating HCV does not completely eliminate the virus from the body. The medications, however, usually decrease the viral load to the point where the infection becomes undetectable.
 
========================
Applications/Usage:
A labelled peptidomimetic inhibitor of hepatitis C virus protease.
 
Conventional therapy typically involved a combination regimen of peginterferon alfa and ribavirin taken for 24 to 48 weeks. Some patients experience difficulty adhering to the treatment as prescribed because of the length of therapy. Other patients discontinue therapy because of the side effects associated with the medications. Of the individuals adhering to the prescribed therapy, up to one half experienced a resurgence of the virus.
 
========================
Side Effect:
Side effects of telaprevir include nausea, vomiting, and diarrhea to the extent of developing rectal irritation. Individuals may also develop anemia experienced as dizziness, shortness of breath, and fatigue followed by generalized weakness. Hematological effects also include decreased numbers of platelets and white blood cells, making patients more susceptible to infection. Patients exhibiting blisters, lesions, or rash on the skin or in the mouth should notify a physician. Individuals should also report fevers, facial swelling, and any reddening of the eyes that resembles conjunctivitis.
 
========================
Notes:
Prior to receiving telaprevir treatment, patients must disclose all medical conditions and current medications taken. Pregnant women cannot undergo the therapy regimen because of possible interference with normal cellular reproduction, and physicians strongly recommend that women use at least two forms of contraception during treatment. The antiviral medication also interacts with numerous medications, including anti-infectives, cholesterol lowering agents, and certain cardiac formulations.
 
 

Pharmaceutical Raw Material Telaprevir with Fast Delivery(CAS: 402957-28-2)
 
========================
Chemical Information:
Quick Details: 
Product Name: Telaprevir
Other Names: Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-;VX-950;VX-950 (Teleprevir);(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;Telaprevir;(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide VX-950;VX-950(Telaprevir);(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxaMido)acetaMido)-3,3-diMethylbutanoyl)-N-((S)-1-(cyclopropylaMino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxaMide
Model No.: CUR-526
CAS No.: 402957-28-2
Molecular Formula: C36H53N7O6
Molecular Weight: 679.85
Appearance: White Solid
Melting Point: N/A
Purity: 99%+
COA: Available
MSDS: Available
Spectrum: Available
Suitable People: ALL People
Product Specifications: Pharmaceutical Grade 
Standard: Qualified
MOQ(Minimum Order Quantity): 10g
Payment: L/C, T/T, Western Union
Shipment: EMS, DHL, FedEx, TNT
Payment:T/T, Western Union and Money Gram
Delivery:Within 24hours After Your Payment
Packing: Aluminium Foil Bag or as Required    
Brand: Biocar
Origion: Hubei,China  
Export Markets: Global   
 
========================
Product Description:
Telaprevir is a peptidomimetic inhibitor of hepatitis C virus protease.
 
Physicians prescribe the antiviral medication telaprevir in conjunction with peginterferon alfa and ribavirin for the treatment of the hepatitis C virus (HCV). The HCV drug not only increases the likelihood of disabling the virus but also may decrease the amount of time patients require treatment. The treatment regimen may cause anemia and typically produces flu-like symptoms. Telaprevir interacts with many prescribed medications.
 
Telaprevir is a protease inhibitor antiviral medication that interferes with the NS3/4A serine protease. This enzyme is responsible for protein maturity and protein adhesion. When these processes are inhibited, the virus cannot replicate. Genotype 1 hepatitis C virus is the most common strain of the disease and is also most resistant to treatment. Treating HCV does not completely eliminate the virus from the body. The medications, however, usually decrease the viral load to the point where the infection becomes undetectable.
 
========================
Applications/Usage:
A labelled peptidomimetic inhibitor of hepatitis C virus protease.
 
Conventional therapy typically involved a combination regimen of peginterferon alfa and ribavirin taken for 24 to 48 weeks. Some patients experience difficulty adhering to the treatment as prescribed because of the length of therapy. Other patients discontinue therapy because of the side effects associated with the medications. Of the individuals adhering to the prescribed therapy, up to one half experienced a resurgence of the virus.
 
========================
Side Effect:
Side effects of telaprevir include nausea, vomiting, and diarrhea to the extent of developing rectal irritation. Individuals may also develop anemia experienced as dizziness, shortness of breath, and fatigue followed by generalized weakness. Hematological effects also include decreased numbers of platelets and white blood cells, making patients more susceptible to infection. Patients exhibiting blisters, lesions, or rash on the skin or in the mouth should notify a physician. Individuals should also report fevers, facial swelling, and any reddening of the eyes that resembles conjunctivitis.
 
========================
Notes:
Prior to receiving telaprevir treatment, patients must disclose all medical conditions and current medications taken. Pregnant women cannot undergo the therapy regimen because of possible interference with normal cellular reproduction, and physicians strongly recommend that women use at least two forms of contraception during treatment. The antiviral medication also interacts with numerous medications, including anti-infectives, cholesterol lowering agents, and certain cardiac formulations.
 
 

Metallurgical Chemicals

Metallurgical Chemicals,Metallurgical Processing Chemical,Calcium Cyanamide Granule,Mining Metallurgical Chemical

Ningxia Darong Chemicals & Metallurgy Co., Ltd. , http://www.darong-cyanamide.com